Join us for the Annual CBRN Defense Conference and Exhibition July 23 – 25, 2018 in Wilmington, DE. The Department of Defense is focused on remapping the way they do business, and they have highlighted industry collaboration as a top priority in order to accomplish readiness and modernization goals for future combat systems, survivability, and securing the nation’s defense.
This conference and exhibition will provide the opportunity to listen to and learn from key leaders in acquisition, understand CBRN requirements, receive in depth information on Other Transactional Agreements, and learn of potential business opportunities in current and future CBRN joint program requirements. The CBRN Defense Conference and Exhibition will also provide a venue that will spotlight emerging CBRN defense national/international technologies; medical solutions and advanced development and manufacturing needs; along with promising research and development opportunities from our interagency partners.
This is an exciting year for the CBRN defense community, as we celebrate the 100th Anniversary of the United Sates Army Chemical Corps celebration at the CBRN Defense Conference and Exhibition. There will be a special Time Capsule Ceremony along with a Cake Cutting Celebration to mark this historic 100th Anniversary.
The conference is hosted by the NDIA CBRN Defense Division and the Chemical Biological Defense Acquisition Initiatives Forum, with attendance from the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense.
The NDIA has a policy of strict compliance with federal and state antitrust laws. The antitrust laws prohibit competitors from engaging in actions that could result in an unreasonable restraint of trade. Consequently, NDIA members must avoid discussing certain topics when they are together – both at formal association membership, board, committee, and other meetings and in informal contacts with other industry members: prices, fees, rates, profit margins, or other terms or conditions of sale (including allowances, credit terms, and warranties); allocation of markets or customers or division of territories; or refusals to deal with or boycotts of suppliers, customers or other third parties, or topics that may lead participants not to deal with a particular supplier, customer or third party.